Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmin Tiro

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Preventive Medicine|January 3, 2021
Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery systemColin Malone, Diana S M Buist, Jasmin Tiro, et al.
The American Journal of Medicine|August 14, 2014
Racial, social, and clinical determinants of hepatocellular carcinoma surveillanceAmit G Singal, Xilong Li, Jasmin Tiro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 4, 2021
Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With CirrhosisAmit G Singal, Yixing Chen, Shrihari Sridhar, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
ReplyOmair Atiq, Jasmin Tiro, Adam C Yopp, et al.
Hepatology (Baltimore, Md.)|October 25, 2016
An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosisOmair Atiq, Jasmin Tiro, Adam C Yopp, et al.
Cancer Causes & Control : CCC|August 6, 2025
Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systemsGaia Pocobelli, Jacquelyn Lykken, Jennifer S Haas, et al.
Plos One|September 8, 2023
Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohortNoa Kopplin, Angie Garcia, Annika Reczek, et al.
Frontiers in Immunology|April 19, 2021
T Cell Receptor Repertoires Acquired <i>via</i> Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk EstimatesScott Christley, Jared Ostmeyer, Lisa Quirk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening in Ontario, Canada--a replication studyPaul Ritvo, Ronald Myers, M L Del Giudice, et al.
Vaccines|April 30, 2021
Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)Madhusudhanan Narasimhan, Lenin Mahimainathan, Ellen Araj, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Preventive Medicine|January 3, 2021
Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery systemColin Malone, Diana S M Buist, Jasmin Tiro, et al.
The American Journal of Medicine|August 14, 2014
Racial, social, and clinical determinants of hepatocellular carcinoma surveillanceAmit G Singal, Xilong Li, Jasmin Tiro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 4, 2021
Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With CirrhosisAmit G Singal, Yixing Chen, Shrihari Sridhar, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
ReplyOmair Atiq, Jasmin Tiro, Adam C Yopp, et al.
Hepatology (Baltimore, Md.)|October 25, 2016
An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosisOmair Atiq, Jasmin Tiro, Adam C Yopp, et al.
Cancer Causes & Control : CCC|August 6, 2025
Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systemsGaia Pocobelli, Jacquelyn Lykken, Jennifer S Haas, et al.
Plos One|September 8, 2023
Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohortNoa Kopplin, Angie Garcia, Annika Reczek, et al.
Frontiers in Immunology|April 19, 2021
T Cell Receptor Repertoires Acquired <i>via</i> Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk EstimatesScott Christley, Jared Ostmeyer, Lisa Quirk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening in Ontario, Canada--a replication studyPaul Ritvo, Ronald Myers, M L Del Giudice, et al.
Vaccines|April 30, 2021
Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)Madhusudhanan Narasimhan, Lenin Mahimainathan, Ellen Araj, et al.
Pageof 3